Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) Summary

Networked: 626 relevant articles (21 outcomes, 57 trials/studies) for this Disease

Key Drugs and Agents for Tricuspid Valve Insufficiency

1. sildenafil (Viagra) : 2 outcomes 1 study in 5 results : FDA 5
   
2. Brain Natriuretic Peptide (Natrecor) : 1 outcome 1 study in 9 results : FDA 1
   
3. Dobutamine : 1 outcome 1 study in 4 results : FDA 15 Generic
   
4. Colloids (Colloid) : 1 outcome 1 study in 2 results : IBA
   
5. SHU 508 (Levovist) : 1 outcome 1 study in 2 results : IBA
   
6. Carbon Monoxide : 1 outcome in 11 results : IBA
   
7. Coenzyme A (CoA) : 1 outcome in 1 result : IBA
   
8. trastuzumab (Herceptin) : 1 outcome in 1 result : FDA 2
   
9. imatinib (Gleevec) : 1 outcome in 1 result : FDA 3
   
10. beraprost : 1 outcome in 1 result : IBA
    

Diseases Related to Tricuspid Valve Insufficiency

1. Mitral Valve Insufficiency (Mitral Regurgitation)
2. Pulmonary Hypertension (Ayerza Syndrome)
3. Heart Failure
4. Dyspnea (Shortness of Breath)
5. Pathologic Constriction (Stenosis)

Key Therapies for Tricuspid Valve Insufficiency

1. Sutures (Suture) : 2 outcomes in 12 results
   
2. Endarterectomy (Thromboendarterectomy) : 2 outcomes in 6 results
   
3. Catheters : 1 outcome 4 studies in 29 results
   
4. Prostheses and Implants (Prosthesis) : 1 outcome 2 studies in 21 results
   
5. Transplantation (Transplant Recipients) : 1 outcome 2 studies in 21 results